Form 8-K - Current report:
SEC Accession No. 0001193125-12-508557
Filing Date
2012-12-19
Accepted
2012-12-19 17:21:04
Documents
6
Period of Report
2012-12-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d456350d8k.htm 8-K 22169
2 PURCHASE AGREEMENT d456350dex11.htm EX-1.1 169683
3 FORM OF DECEMBER 2012 WARRANT d456350dex41.htm EX-4.1 81308
4 OPINION OF TROYGOULD PC d456350dex51.htm EX-5.1 8873
5 PRESS RELEASE DECEMBER 18, 2012 d456350dex992.htm EX-99.2 9141
6 GRAPHIC g456350g58t22.jpg GRAPHIC 5404
  Complete submission text file 0001193125-12-508557.txt   300276
Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 121275204
SIC: 2834 Pharmaceutical Preparations